The global Colorectal Cancer Therapeutics market was valued at US$ 12130 million in 2023 and is anticipated to reach US$ 17070 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

Colorectal Cancer Therapeutics Market

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Therapeutics.

Report Scope

The Colorectal Cancer Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Colorectal Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Colorectal Cancer Therapeutics Market Report

Report Metric	Details
Report Name	Colorectal Cancer Therapeutics Market
Accounted market size in 2023	US$ 12130 million
Forecasted market size in 2030	US$ 17070 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Diagnostics Therapeutics
Segment by Application	Hospitals Clinic Research Institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Hutchison MediPharma, Jiangsu Hengrui Medicine, Jiangsu Chia-Tai Tianqing, Suzhou Zelgen Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Colorectal Cancer Therapeutics Market growing?

Ans: The Colorectal Cancer Therapeutics Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the Colorectal Cancer Therapeutics Market size in 2030?

Ans: The Colorectal Cancer Therapeutics Market size in 2030 will be US$ 17070 million.

Who are the main players in the Colorectal Cancer Therapeutics Market report?

Ans: The main players in the Colorectal Cancer Therapeutics Market are Taiho Pharma, Merck KGaA, Amgen, Takeda, Roche, Eli Lilly, Sanofi, Regeneron, Bayer, Onyx, Bristol-Myers Squib, Sumitomo Dainippon Pharma, Array BioPharma, Hutchison MediPharma, Jiangsu Hengrui Medicine, Jiangsu Chia-Tai Tianqing, Suzhou Zelgen Biopharmaceuticals

What are the Application segmentation covered in the Colorectal Cancer Therapeutics Market report?

Ans: The Applications covered in the Colorectal Cancer Therapeutics Market report are Hospitals, Clinic, Research Institutions

What are the Type segmentation covered in the Colorectal Cancer Therapeutics Market report?

Ans: The Types covered in the Colorectal Cancer Therapeutics Market report are Diagnostics, Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Diagnostics

1.2.3 Therapeutics

1.3 Market by Application

1.3.1 Global Colorectal Cancer Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Research Institutions

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Colorectal Cancer Therapeutics Market Perspective (2019-2030)

2.2 Colorectal Cancer Therapeutics Growth Trends by Region

2.2.1 Global Colorectal Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Colorectal Cancer Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Colorectal Cancer Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Colorectal Cancer Therapeutics Market Dynamics

2.3.1 Colorectal Cancer Therapeutics Industry Trends

2.3.2 Colorectal Cancer Therapeutics Market Drivers

2.3.3 Colorectal Cancer Therapeutics Market Challenges

2.3.4 Colorectal Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Colorectal Cancer Therapeutics Players by Revenue

3.1.1 Global Top Colorectal Cancer Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Colorectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Colorectal Cancer Therapeutics Revenue

3.4 Global Colorectal Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Colorectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Therapeutics Revenue in 2023

3.5 Colorectal Cancer Therapeutics Key Players Head office and Area Served

3.6 Key Players Colorectal Cancer Therapeutics Product Solution and Service

3.7 Date of Enter into Colorectal Cancer Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Therapeutics Breakdown Data by Type

4.1 Global Colorectal Cancer Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2025-2030)

5 Colorectal Cancer Therapeutics Breakdown Data by Application

5.1 Global Colorectal Cancer Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Colorectal Cancer Therapeutics Market Size (2019-2030)

6.2 North America Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Colorectal Cancer Therapeutics Market Size by Country (2019-2024)

6.4 North America Colorectal Cancer Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Colorectal Cancer Therapeutics Market Size (2019-2030)

7.2 Europe Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Colorectal Cancer Therapeutics Market Size by Country (2019-2024)

7.4 Europe Colorectal Cancer Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Colorectal Cancer Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Colorectal Cancer Therapeutics Market Size (2019-2030)

9.2 Latin America Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Colorectal Cancer Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Colorectal Cancer Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Colorectal Cancer Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Taiho Pharma

11.1.1 Taiho Pharma Company Detail

11.1.2 Taiho Pharma Business Overview

11.1.3 Taiho Pharma Colorectal Cancer Therapeutics Introduction

11.1.4 Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.1.5 Taiho Pharma Recent Development

11.2 Merck KGaA

11.2.1 Merck KGaA Company Detail

11.2.2 Merck KGaA Business Overview

11.2.3 Merck KGaA Colorectal Cancer Therapeutics Introduction

11.2.4 Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.2.5 Merck KGaA Recent Development

11.3 Amgen

11.3.1 Amgen Company Detail

11.3.2 Amgen Business Overview

11.3.3 Amgen Colorectal Cancer Therapeutics Introduction

11.3.4 Amgen Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.3.5 Amgen Recent Development

11.4 Takeda

11.4.1 Takeda Company Detail

11.4.2 Takeda Business Overview

11.4.3 Takeda Colorectal Cancer Therapeutics Introduction

11.4.4 Takeda Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.4.5 Takeda Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Colorectal Cancer Therapeutics Introduction

11.5.4 Roche Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.5.5 Roche Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Colorectal Cancer Therapeutics Introduction

11.6.4 Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.6.5 Eli Lilly Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Detail

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Colorectal Cancer Therapeutics Introduction

11.7.4 Sanofi Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.7.5 Sanofi Recent Development

11.8 Regeneron

11.8.1 Regeneron Company Detail

11.8.2 Regeneron Business Overview

11.8.3 Regeneron Colorectal Cancer Therapeutics Introduction

11.8.4 Regeneron Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.8.5 Regeneron Recent Development

11.9 Bayer

11.9.1 Bayer Company Detail

11.9.2 Bayer Business Overview

11.9.3 Bayer Colorectal Cancer Therapeutics Introduction

11.9.4 Bayer Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.9.5 Bayer Recent Development

11.10 Onyx

11.10.1 Onyx Company Detail

11.10.2 Onyx Business Overview

11.10.3 Onyx Colorectal Cancer Therapeutics Introduction

11.10.4 Onyx Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.10.5 Onyx Recent Development

11.11 Bristol-Myers Squib

11.11.1 Bristol-Myers Squib Company Detail

11.11.2 Bristol-Myers Squib Business Overview

11.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Introduction

11.11.4 Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.11.5 Bristol-Myers Squib Recent Development

11.12 Sumitomo Dainippon Pharma

11.12.1 Sumitomo Dainippon Pharma Company Detail

11.12.2 Sumitomo Dainippon Pharma Business Overview

11.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Introduction

11.12.4 Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.12.5 Sumitomo Dainippon Pharma Recent Development

11.13 Array BioPharma

11.13.1 Array BioPharma Company Detail

11.13.2 Array BioPharma Business Overview

11.13.3 Array BioPharma Colorectal Cancer Therapeutics Introduction

11.13.4 Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.13.5 Array BioPharma Recent Development

11.14 Hutchison MediPharma

11.14.1 Hutchison MediPharma Company Detail

11.14.2 Hutchison MediPharma Business Overview

11.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Introduction

11.14.4 Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.14.5 Hutchison MediPharma Recent Development

11.15 Jiangsu Hengrui Medicine

11.15.1 Jiangsu Hengrui Medicine Company Detail

11.15.2 Jiangsu Hengrui Medicine Business Overview

11.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Introduction

11.15.4 Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.15.5 Jiangsu Hengrui Medicine Recent Development

11.16 Jiangsu Chia-Tai Tianqing

11.16.1 Jiangsu Chia-Tai Tianqing Company Detail

11.16.2 Jiangsu Chia-Tai Tianqing Business Overview

11.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Introduction

11.16.4 Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.16.5 Jiangsu Chia-Tai Tianqing Recent Development

11.17 Suzhou Zelgen Biopharmaceuticals

11.17.1 Suzhou Zelgen Biopharmaceuticals Company Detail

11.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview

11.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Introduction

11.17.4 Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2019-2024)

11.17.5 Suzhou Zelgen Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sumitomo Dainippon Pharma

Array BioPharma

Hutchison MediPharma

Jiangsu Hengrui Medicine

Jiangsu Chia-Tai Tianqing

Suzhou Zelgen Biopharmaceuticals

List of Tables

Table 1. Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Diagnostics

Table 3. Key Players of Therapeutics

Table 4. Global Colorectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Colorectal Cancer Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Colorectal Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Colorectal Cancer Therapeutics Market Share by Region (2019-2024)

Table 8. Global Colorectal Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Colorectal Cancer Therapeutics Market Share by Region (2025-2030)

Table 10. Colorectal Cancer Therapeutics Market Trends

Table 11. Colorectal Cancer Therapeutics Market Drivers

Table 12. Colorectal Cancer Therapeutics Market Challenges

Table 13. Colorectal Cancer Therapeutics Market Restraints

Table 14. Global Colorectal Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Colorectal Cancer Therapeutics Market Share by Players (2019-2024)

Table 16. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2023)

Table 17. Ranking of Global Top Colorectal Cancer Therapeutics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Colorectal Cancer Therapeutics Product Solution and Service

Table 21. Date of Enter into Colorectal Cancer Therapeutics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Colorectal Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Colorectal Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2019-2024)

Table 29. Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2025-2030)

Table 31. North America Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Colorectal Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Colorectal Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Taiho Pharma Company Detail

Table 47. Taiho Pharma Business Overview

Table 48. Taiho Pharma Colorectal Cancer Therapeutics Product

Table 49. Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 50. Taiho Pharma Recent Development

Table 51. Merck KGaA Company Detail

Table 52. Merck KGaA Business Overview

Table 53. Merck KGaA Colorectal Cancer Therapeutics Product

Table 54. Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 55. Merck KGaA Recent Development

Table 56. Amgen Company Detail

Table 57. Amgen Business Overview

Table 58. Amgen Colorectal Cancer Therapeutics Product

Table 59. Amgen Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 60. Amgen Recent Development

Table 61. Takeda Company Detail

Table 62. Takeda Business Overview

Table 63. Takeda Colorectal Cancer Therapeutics Product

Table 64. Takeda Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Roche Company Detail

Table 67. Roche Business Overview

Table 68. Roche Colorectal Cancer Therapeutics Product

Table 69. Roche Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 70. Roche Recent Development

Table 71. Eli Lilly Company Detail

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly Colorectal Cancer Therapeutics Product

Table 74. Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 75. Eli Lilly Recent Development

Table 76. Sanofi Company Detail

Table 77. Sanofi Business Overview

Table 78. Sanofi Colorectal Cancer Therapeutics Product

Table 79. Sanofi Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Sanofi Recent Development

Table 81. Regeneron Company Detail

Table 82. Regeneron Business Overview

Table 83. Regeneron Colorectal Cancer Therapeutics Product

Table 84. Regeneron Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Regeneron Recent Development

Table 86. Bayer Company Detail

Table 87. Bayer Business Overview

Table 88. Bayer Colorectal Cancer Therapeutics Product

Table 89. Bayer Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 90. Bayer Recent Development

Table 91. Onyx Company Detail

Table 92. Onyx Business Overview

Table 93. Onyx Colorectal Cancer Therapeutics Product

Table 94. Onyx Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 95. Onyx Recent Development

Table 96. Bristol-Myers Squib Company Detail

Table 97. Bristol-Myers Squib Business Overview

Table 98. Bristol-Myers Squib Colorectal Cancer Therapeutics Product

Table 99. Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 100. Bristol-Myers Squib Recent Development

Table 101. Sumitomo Dainippon Pharma Company Detail

Table 102. Sumitomo Dainippon Pharma Business Overview

Table 103. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product

Table 104. Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 105. Sumitomo Dainippon Pharma Recent Development

Table 106. Array BioPharma Company Detail

Table 107. Array BioPharma Business Overview

Table 108. Array BioPharma Colorectal Cancer Therapeutics Product

Table 109. Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 110. Array BioPharma Recent Development

Table 111. Hutchison MediPharma Company Detail

Table 112. Hutchison MediPharma Business Overview

Table 113. Hutchison MediPharma Colorectal Cancer Therapeutics Product

Table 114. Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 115. Hutchison MediPharma Recent Development

Table 116. Jiangsu Hengrui Medicine Company Detail

Table 117. Jiangsu Hengrui Medicine Business Overview

Table 118. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product

Table 119. Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 120. Jiangsu Hengrui Medicine Recent Development

Table 121. Jiangsu Chia-Tai Tianqing Company Detail

Table 122. Jiangsu Chia-Tai Tianqing Business Overview

Table 123. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product

Table 124. Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 125. Jiangsu Chia-Tai Tianqing Recent Development

Table 126. Suzhou Zelgen Biopharmaceuticals Company Detail

Table 127. Suzhou Zelgen Biopharmaceuticals Business Overview

Table 128. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product

Table 129. Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 130. Suzhou Zelgen Biopharmaceuticals Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Colorectal Cancer Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Colorectal Cancer Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Diagnostics Features

Figure 4. Therapeutics Features

Figure 5. Global Colorectal Cancer Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Colorectal Cancer Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinic Case Studies

Figure 9. Research Institutions Case Studies

Figure 10. Colorectal Cancer Therapeutics Report Years Considered

Figure 11. Global Colorectal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Colorectal Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Colorectal Cancer Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Colorectal Cancer Therapeutics Market Share by Players in 2023

Figure 15. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Therapeutics Revenue in 2023

Figure 17. North America Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Colorectal Cancer Therapeutics Market Share by Country (2019-2030)

Figure 19. United States Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Colorectal Cancer Therapeutics Market Share by Country (2019-2030)

Figure 23. Germany Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Colorectal Cancer Therapeutics Market Share by Region (2019-2030)

Figure 31. China Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Colorectal Cancer Therapeutics Market Share by Country (2019-2030)

Figure 39. Mexico Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Colorectal Cancer Therapeutics Market Share by Country (2019-2030)

Figure 43. Turkey Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Colorectal Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 46. Merck KGaA Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 47. Amgen Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 48. Takeda Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 49. Roche Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 50. Eli Lilly Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 51. Sanofi Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 52. Regeneron Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 53. Bayer Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 54. Onyx Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 55. Bristol-Myers Squib Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 56. Sumitomo Dainippon Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 57. Array BioPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 58. Hutchison MediPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 59. Jiangsu Hengrui Medicine Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 60. Jiangsu Chia-Tai Tianqing Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 61. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions